Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: J Bone Miner Res. 2017 Mar 23;32(6):1267–1273. doi: 10.1002/jbmr.3109

Figure 2.

Figure 2

%COP cells (grey line) increased with teriparatide, peaking at 3 months by 221% (p=0.02). IGF-1R expression (black line, lower line) also increased, peaking at 3 months by 128% (p=0.009)